Sac-TMT for Active TNBC Brain Metastases
NCT07458113
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Triple Negative Breast Cancers
Interventions
DRUG:
Sacituzumab tirumotecan
Sponsor
Yale University
Collaborators
[object Object]
[object Object]
[object Object]